vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Azenta, Inc. is the larger business by last-quarter revenue ($148.6M vs $140.7M, roughly 1.1× Purple Innovation, Inc.). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -10.4%, a 8.1% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs 0.8%). Azenta, Inc. produced more free cash flow last quarter ($14.7M vs $-7.8M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs 4.4%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
AZTA vs PRPL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $140.7M |
| Net Profit | $-15.4M | $-3.2M |
| Gross Margin | 42.9% | 41.9% |
| Operating Margin | -4.9% | -1.6% |
| Net Margin | -10.4% | -2.3% |
| Revenue YoY | 0.8% | 9.1% |
| Net Profit YoY | -15.7% | 62.1% |
| EPS (diluted) | $-0.34 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.6M | $140.7M | ||
| Q3 25 | $159.2M | $118.8M | ||
| Q2 25 | $143.9M | $105.1M | ||
| Q1 25 | $143.3M | $104.2M | ||
| Q4 24 | $147.4M | $129.0M | ||
| Q3 24 | $150.6M | $118.6M | ||
| Q2 24 | $144.3M | $120.3M | ||
| Q1 24 | $136.4M | $120.0M |
| Q4 25 | $-15.4M | $-3.2M | ||
| Q3 25 | $50.9M | $-11.7M | ||
| Q2 25 | $-48.0M | $-17.3M | ||
| Q1 25 | $-47.7M | $-19.1M | ||
| Q4 24 | $-11.0M | $-8.5M | ||
| Q3 24 | $-6.6M | $-39.2M | ||
| Q2 24 | $-6.6M | $27.0K | ||
| Q1 24 | $-137.4M | $-50.2M |
| Q4 25 | 42.9% | 41.9% | ||
| Q3 25 | 45.4% | 42.8% | ||
| Q2 25 | 46.2% | 35.9% | ||
| Q1 25 | 43.8% | 39.4% | ||
| Q4 24 | 46.7% | 42.9% | ||
| Q3 24 | 45.5% | 29.7% | ||
| Q2 24 | 44.8% | 40.7% | ||
| Q1 24 | 43.8% | 34.8% |
| Q4 25 | -4.9% | -1.6% | ||
| Q3 25 | 1.2% | -10.2% | ||
| Q2 25 | -1.3% | -13.5% | ||
| Q1 25 | -12.7% | -13.9% | ||
| Q4 24 | -5.9% | -6.0% | ||
| Q3 24 | -3.1% | -39.5% | ||
| Q2 24 | -4.9% | -12.1% | ||
| Q1 24 | -18.1% | -19.3% |
| Q4 25 | -10.4% | -2.3% | ||
| Q3 25 | 32.0% | -9.9% | ||
| Q2 25 | -33.4% | -16.5% | ||
| Q1 25 | -33.3% | -18.4% | ||
| Q4 24 | -7.5% | -6.6% | ||
| Q3 24 | -4.4% | -33.1% | ||
| Q2 24 | -4.5% | 0.0% | ||
| Q1 24 | -100.8% | -41.8% |
| Q4 25 | $-0.34 | $0.03 | ||
| Q3 25 | $1.12 | $0.11 | ||
| Q2 25 | $-1.05 | $0.16 | ||
| Q1 25 | $-1.04 | $0.18 | ||
| Q4 24 | $-0.25 | $0.08 | ||
| Q3 24 | $-0.25 | $0.36 | ||
| Q2 24 | $-0.12 | $0.00 | ||
| Q1 24 | $-2.48 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $1.7B | $-29.7M |
| Total Assets | $2.1B | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $336.6M | $24.3M | ||
| Q3 25 | $279.8M | $32.4M | ||
| Q2 25 | $270.0M | $34.2M | ||
| Q1 25 | $253.6M | $21.6M | ||
| Q4 24 | $377.5M | $29.0M | ||
| Q3 24 | $280.0M | $23.4M | ||
| Q2 24 | $336.5M | $23.4M | ||
| Q1 24 | $353.5M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.7B | $-29.7M | ||
| Q3 25 | $1.7B | $-26.9M | ||
| Q2 25 | $1.7B | $-15.6M | ||
| Q1 25 | $1.7B | $1.3M | ||
| Q4 24 | $1.7B | $20.2M | ||
| Q3 24 | $1.8B | $28.0M | ||
| Q2 24 | $2.0B | $66.4M | ||
| Q1 24 | $2.2B | $65.5M |
| Q4 25 | $2.1B | $296.3M | ||
| Q3 25 | $2.1B | $302.1M | ||
| Q2 25 | $2.0B | $303.8M | ||
| Q1 25 | $2.0B | $293.8M | ||
| Q4 24 | $2.0B | $307.8M | ||
| Q3 24 | $2.1B | $309.3M | ||
| Q2 24 | $2.3B | $362.1M | ||
| Q1 24 | $2.6B | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $-5.8M |
| Free Cash FlowOCF − Capex | $14.7M | $-7.8M |
| FCF MarginFCF / Revenue | 9.9% | -5.5% |
| Capex IntensityCapex / Revenue | 4.2% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.8M | $-5.8M | ||
| Q3 25 | $2.2M | $-968.0K | ||
| Q2 25 | $25.8M | $-4.0M | ||
| Q1 25 | $14.4M | $-23.1M | ||
| Q4 24 | $29.8M | $6.8M | ||
| Q3 24 | $17.7M | $1.1M | ||
| Q2 24 | $9.8M | $-8.9M | ||
| Q1 24 | $8.7M | $-16.8M |
| Q4 25 | $14.7M | $-7.8M | ||
| Q3 25 | $-5.7M | $-1.8M | ||
| Q2 25 | $15.0M | $-7.0M | ||
| Q1 25 | $7.0M | $-25.3M | ||
| Q4 24 | $22.0M | $5.7M | ||
| Q3 24 | $8.3M | $101.0K | ||
| Q2 24 | $1.3M | $-11.0M | ||
| Q1 24 | $428.0K | $-19.9M |
| Q4 25 | 9.9% | -5.5% | ||
| Q3 25 | -3.6% | -1.5% | ||
| Q2 25 | 10.4% | -6.6% | ||
| Q1 25 | 4.9% | -24.3% | ||
| Q4 24 | 15.0% | 4.4% | ||
| Q3 24 | 5.5% | 0.1% | ||
| Q2 24 | 0.9% | -9.2% | ||
| Q1 24 | 0.3% | -16.5% |
| Q4 25 | 4.2% | 1.4% | ||
| Q3 25 | 4.9% | 0.7% | ||
| Q2 25 | 7.5% | 2.8% | ||
| Q1 25 | 5.2% | 2.2% | ||
| Q4 24 | 5.3% | 0.8% | ||
| Q3 24 | 6.2% | 0.9% | ||
| Q2 24 | 5.9% | 1.7% | ||
| Q1 24 | 6.1% | 2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
